Key Takeaways
- Lifetime prevalence of Social Anxiety Disorder (SAD) in the United States among adults aged 18 and older is 13.0%
- Past year prevalence of SAD in US adults is 7.1%, affecting approximately 15 million adults
- Globally, the 12-month prevalence of SAD is around 4-13%, with variations by country
- SAD is characterized by intense fear of social situations where scrutiny is possible, lasting 6 months or more
- Common symptoms include blushing, sweating, trembling, and rapid heartbeat in 75% of SAD patients
- Avoidance of social situations occurs in 60-70% of individuals with SAD
- Genetic heritability of SAD is 51%, from twin studies
- First-degree relatives of SAD patients have 2-6x higher risk
- Childhood maltreatment increases SAD risk by 2.5-fold
- CBT remission rates for SAD reach 50-75% after 12-16 sessions
- SSRIs like paroxetine achieve 50-60% response rate in SAD
- Exposure therapy reduces LSAS scores by 40-50% in 8 weeks
- SAD comorbid with depression in 45-60% of cases
- Alcohol use disorder comorbidity rate 20-40% in SAD patients
- Suicide attempt risk 2.7x higher in SAD vs general population
Social anxiety disorder affects millions globally with intense fear in social situations.
Causes and Risk Factors
Causes and Risk Factors Interpretation
Impact and Comorbidities
Impact and Comorbidities Interpretation
Prevalence and Epidemiology
Prevalence and Epidemiology Interpretation
Symptoms and Diagnosis
Symptoms and Diagnosis Interpretation
Treatment and Management
Treatment and Management Interpretation
Sources & References
- Reference 1NIMHnimh.nih.govVisit source
- Reference 2ADAAadaa.orgVisit source
- Reference 3WHOwho.intVisit source
- Reference 4PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 5JAMANETWORKjamanetwork.comVisit source
- Reference 6AIHWaihw.gov.auVisit source
- Reference 7NCBIncbi.nlm.nih.govVisit source
- Reference 8NICEnice.org.ukVisit source
- Reference 9STATCANwww150.statcan.gc.caVisit source
- Reference 10MENTALHEALTHmentalhealth.org.nzVisit source
- Reference 11PTSDptsd.va.govVisit source
- Reference 12DSM5dsm5.orgVisit source
- Reference 13MAYOCLINICmayoclinic.orgVisit source
- Reference 14PSYCHOLOGYTODAYpsychologytoday.comVisit source
- Reference 15AACAPaacap.orgVisit source





